Skip to main content
. 2018 Mar;47(3):327–334.

Table 1:

Description of measured parameters according to the incremental severity of sarcopenia status

Variables Total (N=201) Non-sarcopenia (n=91/45%) Pre-sarcopenia (n=84/42%) Sarcopenia (n=26/13%) P for linear trends
Demographic Measures
  Age (yr) 74.3±6.6 72.2±6.7 75.9±5.8 76.6±6.5 < .001
  Post menopause (yr) 49.4±5.3 50.0±5.5 49.1±4.5 48.8±6.4 .537
  Educational background (yr) 6.1±4.1 7.2±3.9 5.1±4.1 5.7±3.9 .002
Body Composition
  BMI (kg/m2) 24.9±3.4 25.2±3.3 25.0±3.1 22.9±3.6 .008
  Body fat (%) 35.3±6.2 34.8±6.1 36.1±5.8 34.9±7.5 .336
  Lean body mass (kg) 34.7±3.4 35.8±2.8 34.4±3.4 31.6±3.2 < .001
  Waist circumference (cm) 86.7±10.3 85.8±9.1 87.6±8.0 84.1±10.4 .153
AWGS definition of Sarcopenia
  ASM index (kg/m2) 5.8±0.6 6.1±0.5 5.8±0.5 5.0±0.3 < .001
  Gait speed (m/s) 1.1±0.3 1.2±0.2 1.1±0.3 1.1±0.2 < .001
  Hand grip strength (kg) 18.7±4.6 21.8±2.5 16.4±4.8 15.0±2.4 < .001
MMSE score 24.6±4.2 25.9±3.3 23.5±4.6 23.6±4.2 < .001
aCES-D score 8.8±9.9 6.4±7.4 10.3±10.7 12.2±12.7 .050
CVD risk factors, n (%) .647
  1 15 (7.5%) 6 (6.6) 7 (8.3) 2 (7.7)
  2 39 (19.4%) 21 (23.1) 12 (14.3) 6 (23.1)
  ≥3 147 (73.1%) 64 (70.3) 65 (77.4) 18 (69.2)
Medication, n (%) .412
  0 32 (16.0%) 13 (14.3) 15 (17.9) 4 (15.4)
  1 68 (33.8%) 30 (33.0) 26 (31.0) 12 (46.1)
  2 63 (31.3%) 34 (37.3) 25 (29.8) 4 (15.4)
  ≥3 38 (18.9%) 14 (15.4) 18 (21.3) 6 (23.1)
Alcohol consumption, n (%) .692
  0 91 (45.3%) 39 (42.9) 42 (50.0) 10 (38.5)
  1–2 97 (48.3%) 44 (48.3) 38 (45.2) 15 (57.7)
  3–5 6 (3.0%) 3 (3.3) 2 (2.4) 1 (3.8)
  ≥5 7 (3.4%) 5 (5.5) 2 (2.4) 0 (0)

ASM: appendicular skeletal muscle mass; MMSE-DS: mini mental state examination of dementia screening; CES-D: the center for epidemiologic studies depression scale; CVD: cardiovascular disease; AWGS: the Asia Working Group for Sarcopenia.

a

Log10 transformed CES-D scores were used for statistical analyses, and its raw scores were presented in the table.